The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
October 1st 2025, 1:00pm
Katie Goodman, RN, BSN, discusses the ways in which artificial intelligence can help speed up the pace of clinical trial accrual
October 1st 2025, 12:00pm
ESMO Congress: Gynecologic Cancers
Experts in the gynecologic cancer landscape highlight their most anticipated presentations ahead of the 2025 ESMO Congress.
September 30th 2025, 2:58pm
PER® Winter Lung Cancer Conference
Misty D. Shields, MD, PhD, discusses the modern role for prophylactic cranial irradiation in extensive-stage SCLC management.
September 30th 2025, 1:00pm
ESMO Congress: Hematologic Malignancies
A preview of the hematologic oncology abstracts and presentations to watch at the 2025 ESMO Congress in Berlin.
September 29th 2025, 7:55pm
Kashyap Patel MD, ABIM, BCMAS, discusses the present challenges with integrating AI tools into community practice.
September 29th 2025, 5:00pm
September 29th 2025, 12:25pm
Jim Chen, MD, discusses how artificial intelligence can aid community oncologists in providing optimal care.
September 29th 2025, 12:40am
Ruemu E. Birhiray, MD, discussed the advantages of using AI-based tools to enhance community-based clinical trials in oncology.
September 28th 2025, 11:30pm
Brian P. Mulherin, MD, discusses using AI tools to improve the implementation of NGS in community oncology practice.
September 28th 2025, 8:10pm
Brian P. Mulherin, MD, discusses how artificial intelligence is helping shape smarter cancer care.
September 28th 2025, 5:56pm
AI-powered clinical decision support systems can help oncologists manage rising information demands without forfeiting autonomy in care delivery.
September 28th 2025, 1:58am
Lalan Wilfong, MD, expands on the value of AI prediction models for consensus on patient prognosis and better end-of-life care in oncology.
September 28th 2025, 1:44am
Douglas Flora, MD, LSSBB, discusses how the use of artificial intelligence tools could improve patient screening and drug development in oncology.
September 28th 2025, 1:35am
Lalan Wilfong, MD, discusses the patient- and provider-facing implications that may result from renewed focus on improving care navigation in oncology.
September 27th 2025, 9:55pm
Doug Flora, MD, FACC, LSSBB, explains how AI is transforming cancer care, urging oncologists to engage and guide its responsible use.
September 26th 2025, 8:22pm
OncLive social media polls reveal which lung cancer abstracts are generating excitement ahead of the 2025 ESMO Congress.
September 26th 2025, 6:00pm
OncLive social media polls reveal which prostate, kidney, and bladder cancer abstracts are generating excitement ahead of the 2025 ESMO Congress.
September 25th 2025, 1:00pm
Ahead of the 2025 ESMO Congress, breast cancer experts share the most anticipated research being presented during the meeting.
September 23rd 2025, 5:48pm
International Myeloma Society Annual Meeting
OncLive heard from myeloma experts about the biggest developments in the field at the 22nd Annual International Myeloma Society Meeting and Exposition.
September 22nd 2025, 1:00pm
International Myeloma Society Annual Meeting
Isa-VRd produced a VGPR or better rate of 87.8% in transplant-ineligible newly diagnosed multiple myeloma.